Doylestown Value Partners, LLC – Trademark Portfolio
Entity Type: 16
Doylestown Value Partners, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include DOYLESTOWN VALUE PARTNERS. The owner is based in West Conshohocken, PA.
300 Four Falls Corporate Center
Suite 260
West Conshohocken, PA 19248
Showing of trademarks Trademarks
Trademark Classifications
Doylestown Value Partners, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Doylestown Value Partners, LLC have?
Doylestown Value Partners, LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Doylestown Value Partners, LLC file in?
Doylestown Value Partners, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are Doylestown Value Partners, LLC's most well-known trademarks?
Doylestown Value Partners, LLC's registered trademark portfolio includes well-known marks such as DOYLESTOWN VALUE PARTNERS. These are among 1 currently registered trademark in the portfolio.
What is Doylestown Value Partners, LLC's trademark registration success rate?
Doylestown Value Partners, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.